Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1987 | 09-1987 | 06-1987 | 03-1987 | 12-1986 | |
| Sales | 990 | 830 | -1,511 | 885 | 803 |
| Cost of Goods | 399 | 608 | -934 | 333 | 229 |
| Gross Profit | 591 | 222 | 280 | 552 | 574 |
| Operating Expenses | 1,407 | 1,822 | -3,633 | 2,023 | 1,995 |
| Operating Income | -417 | -993 | 2,122 | -1,138 | -1,192 |
| Interest Expense | 119 | 109 | -220 | 83 | 77 |
| Other Income | 102 | 260 | 810 | 135 | 186 |
| Pre-tax Income | -433 | -842 | 3,152 | -1,086 | -1,083 |
| Income Tax | 11 | 25 | 17 | 19 | 14 |
| Net Income Continuous | -381 | -866 | 3,135 | -1,105 | -1,096 |
| Net Income Discontinuous | 0 | 0 | -4,150 | 0 | 0 |
| Net Income | $-381 | $-866 | $-1,015 | $-1,105 | $-1,096 |
| EPS Basic Total Ops | N/A | N/A | -0.22 | N/A | -0.23 |
| EPS Basic Continuous Ops | N/A | N/A | 0.69 | N/A | -0.23 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.91 | N/A | N/A |
| EPS Diluted Total Ops | N/A | N/A | -0.22 | N/A | -0.23 |
| EPS Diluted Continuous Ops | N/A | N/A | 0.69 | N/A | -0.23 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.91 | N/A | N/A |
| EBITDA(a) | $-417 | $-993 | $2,122 | $-1,138 | $-1,192 |